Literature DB >> 17389303

Genetic diagnosis in Lafora disease: genotype-phenotype correlations and diagnostic pitfalls.

H Lohi1, J Turnbull, X C Zhao, S Pullenayegum, L Ianzano, M Yahyaoui, M A Mikati, N P Quinn, S Franceschetti, F Zara, B A Minassian.   

Abstract

Lafora disease (LD) can be diagnosed by skin biopsy, but this approach has both false negatives and false positives. Biopsies of other organs can also be diagnostic but are more invasive. Genetic diagnosis is also possible but can be inconclusive, for example, in patients with only one heterozygous EPM2A mutation and patients with apparently homozygous EPM2B mutations where one parent is not a carrier of the mutation. We sought to identify occult mutations and clarify the genotypes and confirm the diagnosis of LD in patients with apparent nonrecessive disease inheritance. We used single nucleotide polymorphism, quantitative PCR, and fluorescent in situ hybridization analyses. We identified large EPM2A and EPM2B deletions undetectable by PCR in the heterozygous state and describe simple methods for their routine detection. We report a coding sequence change in several patients and describe why the pathogenic role of this change remains unclear. We confirm that adult-onset LD is due to EPM2B mutations. Finally, we report major intrafamilial heterogeneity in age at onset in LD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17389303     DOI: 10.1212/01.wnl.0000258561.02248.2f

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  11 in total

1.  Late-onset polyglucosan body myopathy in five patients with a homozygous mutation in GYG1.

Authors:  H Orhan Akman; Yavuz Aykit; Ozge Ceren Amuk; Edoardo Malfatti; Norma B Romero; Maria Antonietta Maioli; Rachele Piras; Salvatore DiMauro; Gianni Marrosu
Journal:  Neuromuscul Disord       Date:  2015-11-10       Impact factor: 4.296

Review 2.  Lafora disease.

Authors:  Julie Turnbull; Erica Tiberia; Pasquale Striano; Pierre Genton; Stirling Carpenter; Cameron A Ackerley; Berge A Minassian
Journal:  Epileptic Disord       Date:  2016-09-01       Impact factor: 1.819

Review 3.  Lafora disease - from pathogenesis to treatment strategies.

Authors:  Felix Nitschke; Saija J Ahonen; Silvia Nitschke; Sharmistha Mitra; Berge A Minassian
Journal:  Nat Rev Neurol       Date:  2018-10       Impact factor: 42.937

4.  Malin decreases glycogen accumulation by promoting the degradation of protein targeting to glycogen (PTG).

Authors:  Carolyn A Worby; Matthew S Gentry; Jack E Dixon
Journal:  J Biol Chem       Date:  2007-12-10       Impact factor: 5.157

Review 5.  Mutation analysis in primary immunodeficiency diseases: case studies.

Authors:  Amy P Hsu; Thomas A Fleisher; Julie E Niemela
Journal:  Curr Opin Allergy Clin Immunol       Date:  2009-12

6.  Epilepsy genetics in Africa: challenges and future perspectives.

Authors:  Guida Landouré; Youssoufa Maiga; Oumar Samassékou; Karamoko Nimaga; Mahamadou Traoré; Kenneth H Fischbeck
Journal:  North Afr Middle East Epilepsy J       Date:  2014 Sep-Oct

7.  Italian cohort of Lafora disease: Clinical features, disease evolution, and genotype-phenotype correlations.

Authors:  Antonella Riva; Alessandro Orsini; Marcello Scala; Vittoria Taramasso; Laura Canafoglia; Giuseppe d'Orsi; Maria Teresa Di Claudio; Carlo Avolio; Alfredo D'Aniello; Maurizio Elia; Silvana Franceschetti; Giancarlo Di Gennaro; Francesca Bisulli; Paolo Tinuper; Maria Tappatà; Antonino Romeo; Elena Freri; Carla Marini; Cinzia Costa; Vito Sofia; Edoardo Ferlazzo; Adriana Magaudda; Pierangelo Veggiotti; Elena Gennaro; Angela Pistorio; Carlo Minetti; Amedeo Bianchi; Salvatore Striano; Roberto Michelucci; Federico Zara; Berge Arakel Minassian; Pasquale Striano
Journal:  J Neurol Sci       Date:  2021-03-20       Impact factor: 3.181

8.  Lafora Disease Masquerading as Hepatic Dysfunction.

Authors:  Faisal Inayat; Waqas Ullah; Hanan T Lodhi; Zarak H Khan; Ghulam Ilyas; Nouman Safdar Ali; Hafez Mohammad A Abdullah
Journal:  Cureus       Date:  2018-08-24

9.  Novel mutation in the NHLRC1 gene in a Malian family with a severe phenotype of Lafora disease.

Authors:  M Traoré; G Landouré; W Motley; M Sangaré; K Meilleur; S Coulibaly; S Traoré; B Niaré; F Mochel; A La Pean; A Vortmeyer; H Mani; K H Fischbeck
Journal:  Neurogenetics       Date:  2009-03-26       Impact factor: 2.660

10.  Unusual Course of Lafora Disease.

Authors:  Rodi Zutt; Gea Drost; Yvonne J Vos; Jan Willem Elting; Irene Miedema; Marina A J Tijssen; Oebele F Brouwer; Bauke M de Jong
Journal:  Epilepsia Open       Date:  2016-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.